Cite
HARVARD Citation
Maruyama, D. et al. (2022). Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Cancer science. 113 (9), pp. 3267-3270. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Maruyama, D. et al. (2022). Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Cancer science. 113 (9), pp. 3267-3270. [Online].